×

img Acces sibility Controls

Research Projects Banner

Research Projects

Development of Novel Purine Nucleoside-Quinoline Conjugates as Effective Inhibitors for Chikungunya and Dengue Viruses

Implementing Organization

Dr. B R Ambedkar National Institute of Technology (NIT), Jalandhar, Punjab
Principal Investigator
Dr. Rakesh Kumar
Dr. B R Ambedkar National Institute of Technology (NIT), Jalandhar, Punjab
CO-Principal Investigator
Prof. shailly Tomar
Indian Institute of Technology (Roorkee)

Project Overview

The re-emergence of vector-borne infections, such as Chikungunya and Dengue, poses a significant health and economic threat worldwide. India, being a densely populated country, is prone to infection outbreaks. The lack of an approved vaccine for these viruses makes the situation vulnerable. Quinoline, a privileged scaffold in medicinal chemistry, remains the preferred pharmacophore in antiviral drug design. Quinoline-derived antimalarial drug, chloroquine, has been reported to inhibit these viruses. Nucleoside analogs are another important class of broad-spectrum antivirals that have shown potency against these viruses. The conjugation of nucleoside scaffolds to bioactive molecules has shown to significantly improve their bioactivity. Novel quinoline-purine nucleoside conjugates (adenosine and deoxyadenosine) conjugates are proposed as effective CHIKV and DENV inhibitors. The study will use an environmentally friendly approach to access a library of novel adenosine and deoxyadenosine conjugates of quinoline N-oxides. Molecular docking studies will be performed with viral proteins to understand their interactions and assess structure activity relations for designing effective inhibitors. Antiviral activities will be assessed through cell-based antiviral assays using previously isolated strains.
Funding Organization
Funding Organization
Anusandhan National Research Foundation (ANRF)
Quick Information
Area of Research
Life Sciences & Biotechnology
Focus Area
Medicinal Chemistry
Start Year
2024
End Year
2027
Sanction Amount
₹ 44.06 L
Status
Ongoing
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :00
Grant :00
arrowtop